デフォルト表紙
市場調査レポート
商品コード
1515376

ウイルスベクター製造市場:ベクタータイプ別、用途別、適応症別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測

Viral Vector Production Market, By Vector Type, By Application, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 390 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
ウイルスベクター製造市場:ベクタータイプ別、用途別、適応症別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測
出版日: 2024年06月24日
発行: AnalystView Market Insights
ページ情報: 英文 390 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ウイルスベクター製造市場規模は2023年に12億9,843万米ドルとなり、2024年から2032年にかけて17.5%のCAGRで拡大

ウイルスベクター製造市場-市場力学

がん、感染症、遺伝性疾患の流行が市場需要を促進

がん、感染症、遺伝性疾患の急増が市場情勢に大きな影響を与えています。これらの疾患による負担の増大は、革新的な治療法、特に遺伝子治療に対する需要の急増に火をつけた。その結果、これらの疾患の有病率が上昇を続ける中、遺伝子治療の開発と製造を促進するためのウイルスベクターの必要性が高まっています。この動向がウイルスベクター製造市場の拡大を後押ししています。さらに、ウイルスベクター製造市場における戦略的な作戦の採用が、その成長軌道にさらに拍車をかけています。各企業は、効率性を強化し、生産能力を拡大し、費用対効果を高めるために、多様な戦略を展開しています。これらの戦略を実施することで、ウイルスベクター製造企業は、ウイルスベクターに対する需要の高まりに効果的に対応し、生産プロセスを最適化し、製造コストを抑制することができます。こうした取り組みが、市場の継続的な成長を支えるものと期待されています。

ウイルスベクター製造市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024-2032年)に約17.5%のCAGRで毎年成長すると予測されています。

ベクタータイプのセグメンテーションに基づくと、アデノ随伴ウイルスが2023年に最大の市場シェアを示すと予測されました。

適応症別では、2023年にはがんが主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

ウイルスベクター製造市場-セグメンテーション分析:

世界のウイルスベクター製造市場は、ベクタータイプ、製品タイプ、適応症、地域に基づいてセグメント化されます。

市場はベクタータイプに基づいて5つのカテゴリーに分けられる:アデノウイルスベクター、レンチウイルスベクター、レトロウイルスベクター、アデノ随伴ウイルスベクター、その他のウイルスベクター。アデノ随伴ウイルス(AAV)ベクターセグメントは、主に遺伝子治療分野での需要急増に牽引され、ウイルスベクター製造市場で支配的なプレーヤーとして浮上しました。Alliance for Regenerative Medicine(ARM)によると、AAVベクターは遺伝子治療の臨床試験で使用される主要なベクターであり、それがこのセグメントの大幅な成長に拍車をかけています。

市場は適応症によって4つのカテゴリーに分けられる:がん、遺伝子疾患、感染症、その他の疾患です。適応症別では、世界的にがんが蔓延していることから、がん分野が2023年の市場収益の大部分を占めています。米国国立がん研究所(National Cancer Institute)の統計によると、2020年には米国だけでも新規がん患者数と死亡者数が増加しています。このようながんの蔓延は、遺伝子治療のような高度な治療に対する需要を促進し、その結果、そのような治療法の開発と研究におけるウイルスベクター製造の必要性を後押ししています。

ウイルスベクター製造市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。北米は、2023年にウイルスベクター製造市場の主要拠点として浮上し、予測期間中もその優位性を維持する見通しです。この成長は、遺伝子治療とウイルスベクター製造における高度なインフラと専門知識を備えた、同地域の強固で確立されたバイオテクノロジーと製薬産業に起因しています。さらに、大手バイオテクノロジー企業や製薬企業、研究機関、学術センターが存在することも市場拡大に寄与しています。さらに、北米は遺伝子治療と先進治療分野の研究開発に対する政府支援と資金提供の恩恵を受けており、同地域を技術革新の最前線に位置づけ、ウイルスベクターベースの治療法の商業化を促進しています。

ウイルスベクター製造市場-競合情勢:

ウイルスベクター製造市場において、企業は競争力を維持するために、パートナーシップ、生産能力拡大、技術進歩など、さまざまな戦略的イニシアチブを採用しています。バイオテクノロジー企業、製造受託機関(CMO)、学術研究機関との提携により、スケーラブルなウイルスベクター製造に不可欠な専門知識、生産設備、規制に関する知識を得ることができます。このようなパートナーシップは、懸濁細胞培養や一過性トランスフェクションのような製造プロセスにおける技術革新を促進し、製造コストと期間を削減しながら、ウイルスベクターの収量と品質を向上させます。さらに、遺伝子治療、ワクチン開発、細胞治療アプリケーションにおけるウイルスベクターに対する需要の高まりに対応できるよう、現在も生産能力の拡大に努めています。さらに、研究開発への投資により、新規ベクタープラットフォーム、生産技術、遺伝子導入戦略の探求が可能になり、治療および研究目的でのウイルスベクターの汎用性と有効性が増強されます。戦略的パートナーシップと技術的進歩を通じて、ウイルスベクター製造市場の企業は市場での地位を強化し、技術革新を推進し、バイオ医薬品と再生医療の進歩に貢献しています。

目次

第1章 ウイルスベクター製造市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ウイルスベクター製造の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ウイルスベクター製造産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ウイルスベクター製造市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ウイルスベクター製造市場情勢

  • ウイルスベクター製造市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ウイルスベクター製造市場:ベクタータイプ別

  • 概要
    • セグメントシェア分析
    • アデノウイルスベクター
    • レンチウイルスベクター
    • レトロウイルスベクター
    • アデノ随伴ウイルスベクター
    • その他のウイルスベクター

第8章 ウイルスベクター製造市場:用途別

  • 概要
    • セグメントシェア分析
    • 遺伝子治療
    • ワクチン学

第9章 ウイルスベクター製造市場:適応症別

  • 概要
    • セグメントシェア分析
    • がん
    • 遺伝性疾患
    • 感染症
    • その他の病気

第10章 ウイルスベクター製造市場:地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析:ウイルスベクター製造業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Danaher Corporation
    • TAKARA HOLDINGS INC.
    • Charles River Laboratories
    • Andelyn Biosciences
    • Thermo Fisher Scientific Inc.
    • Novartis AG
    • Avid Bioservices, Inc.
    • Lonza
    • FinVector O
    • Oxford Biomedica
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Viral Vector Production Market: Vector Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vector Type
  • TABLE Global Viral Vector Production Market, by Vector Type 2019-2032 (USD Million)
  • TABLE Viral Vector Production Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Viral Vector Production Market, by Application 2019-2032 (USD Million)
  • TABLE Viral Vector Production Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Viral Vector Production Market, by Indication 2019-2032 (USD Million)
  • TABLE Viral Vector Production Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Viral Vector Production Market, by Region 2019-2032 (USD Million)
  • TABLE North America Viral Vector Production Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Viral Vector Production Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE North America Viral Vector Production Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Viral Vector Production Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector Production Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector Production Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector Production Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Viral Vector Production Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector Production Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector Production Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector Production Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Viral Vector Production Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector Production Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector Production Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector Production Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Viral Vector Production Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector Production Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector Production Market, by Vector Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector Production Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Viral Vector Production Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • FIGURE Viral Vector Production Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vector Type segment market share analysis, 2023 & 2032
  • FIGURE Vector Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Viral Vector Production Market share and leading players, 2023
  • FIGURE Europe Viral Vector Production Market share and leading players, 2023
  • FIGURE Asia Pacific Viral Vector Production Market share and leading players, 2023
  • FIGURE Latin America Viral Vector Production Market share and leading players, 2023
  • FIGURE Middle East and Africa Viral Vector Production Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Viral Vector Production Market share analysis by country, 2023
  • FIGURE Germany Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Viral Vector Production Market share analysis by country, 2023
  • FIGURE India Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Viral Vector Production Market share analysis by country, 2023
  • FIGURE Brazil Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Viral Vector Production Market share analysis by country, 2023
  • FIGURE Saudi Arabia Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Viral Vector Production Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3140

REPORT HIGHLIGHT

Viral Vector Production Market size was valued at USD 1,298.43 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.

Genetically engineered viral vectors serve as vehicles to deliver specific genes or genetic material into cells, playing a vital role in biotechnology and gene therapy. Their primary functions include introducing therapeutic genes, rectifying genetic abnormalities, and modulating cellular functions. Adenoviruses (AdV), adeno-associated viruses (AAV), lentiviruses, retroviruses, among others, constitute the common types of viral vectors utilized in biotechnology. Adenoviral vectors, originating from adenoviruses responsible for human respiratory illnesses, and AAV vectors, derived from non-pathogenic viruses reliant on co-infection with helper viruses like adenoviruses for replication, are prominent examples. These versatile vectors find extensive applications across the biotechnology and pharmaceutical sectors, catalyzing significant advancements in gene therapy and biotechnological research. They have transformed these domains, facilitating the creation of innovative treatments and tools for elucidating and controlling genetic mechanisms.

Viral Vector Production Market- Market Dynamics

Rise in prevalence of cancer, infectious diseases, and genetic disorders to propel market demand

The surge in the prevalence of cancer, infectious diseases, and genetic disorders has profoundly influenced the market landscape. The escalating burden of these conditions has sparked a surge in demand for innovative therapies, notably gene therapy. Consequently, there's a corresponding uptick in the need for viral vectors to facilitate the development and manufacturing of gene therapies, as the prevalence of these ailments continues to climb. This trend has propelled the expansion of the viral vector production market. Moreover, the adoption of strategic maneuvers within the viral vector production market has further fueled its growth trajectory. Companies are deploying diverse strategies to bolster efficiency, expand production capacity, and enhance cost-effectiveness. By implementing these strategies, viral vector production firms can effectively meet the escalating demand for viral vectors, optimize production processes, and curtail manufacturing costs. These efforts are expected to underpin the continued growth of the market.

Viral Vector Production Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.5% over the forecast period (2024-2032)

Based on Vector Type segmentation, adeno-associated viruses were predicted to show maximum market share in the year 2023

Based on Indication segmentation, cancer was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Viral Vector Production Market- Segmentation Analysis:

The Global Viral Vector Production Market is segmented based on Vector Type, Application, Indication, and Region.

The market is divided into five categories based on Vector Type: Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors and Other Viral Vectors. The adeno-associated viruses (AAV) vectors segment emerged as the dominant player in the viral vector production market, primarily driven by soaring demand in the gene therapy sector. According to the Alliance for Regenerative Medicine (ARM), AAV vectors constituted the primary vector used in gene therapy clinical trials, thereby fueling significant growth in this segment.

The market is divided into four categories based on Indication: Cancer, Genetic Disorders, Infectious Diseases and Other Diseases. In terms of indication, the cancer segment claimed the lion's share of the market revenue in 2023, owing to the pervasive prevalence of cancer worldwide. Statistics from the National Cancer Institute indicate an increasing number of new cancer cases and deaths in the U.S. alone in 2020. This widespread incidence of cancer has propelled the demand for advanced therapies like gene therapy, consequently driving the need for viral vector production in the development and research of such therapies.

Viral Vector Production Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America emerged as a major stronghold in the viral vector production market in 2023 and is poised to sustain its dominance in the forecast period. This growth can be attributed to the robust and well-established biotechnology and pharmaceutical industry in the region, equipped with advanced infrastructure and expertise in gene therapy and viral vector production. Additionally, the presence of leading biotech and pharmaceutical companies, research institutions, and academic centers further contributes to market expansion. Moreover, North America benefits from substantial government support and funding for research and development in the field of gene therapy and advanced therapeutics, positioning the region at the forefront of innovation and expediting the commercialization of viral vector-based therapies.

Viral Vector Production Market- Competitive Landscape:

In the Viral Vector Production market, companies employ various strategic initiatives such as partnerships, capacity expansion, and technological advancements to uphold their competitive edge. Collaborations with biotechnology firms, contract manufacturing organizations (CMOs), and academic research institutions provide access to specialized expertise, production facilities, and regulatory knowledge crucial for scalable viral vector manufacturing. These partnerships foster innovation in production processes, like suspension cell culture and transient transfection, enhancing viral vector yields and quality while reducing production costs and timelines. Additionally, ongoing capacity expansion endeavors ensure companies can meet the escalating demand for viral vectors in gene therapy, vaccine development, and cell therapy applications. Furthermore, investments in research and development enable the exploration of novel vector platforms, production technologies, and gene delivery strategies, augmenting the versatility and efficacy of viral vectors for therapeutic and research purposes. Through strategic partnerships and technological advancements, companies in the Viral Vector Production market fortify their market position, drive innovation, and contribute to advancements in biopharmaceuticals and regenerative medicine.

Recent Developments:

In July 2022, Takara Bio Inc. introduced a new Contract Development and Manufacturing Organization (CDMO) service utilizing a brain-tropic adeno-associated virus (AAV) vector called "CereAAV" for clients in the gene and cell therapy industry.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIRAL VECTOR PRODUCTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Danaher Corporation

TAKARA HOLDINGS INC.

Charles River Laboratories

Andelyn Biosciences

Thermo Fisher Scientific Inc.

Novartis AG

Avid Bioservices, Inc.

Lonza

FinVector O

Oxford Biomedica

Others

GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY VECTOR TYPE - MARKET ANALYSIS, 2019 - 2032

  • Adenoviral Vectors
  • Lentiviral Vectors
  • Retroviral Vectors
  • Adeno-Associated Viral Vectors
  • Other Viral Vectors

GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Gene Therapy
  • Vaccinology

GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Cancer
  • Genetic Disorders
  • Infectious Diseases
  • Other Diseases

GLOBAL VIRAL VECTOR PRODUCTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Viral Vector Production Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Viral Vector Production Market Snippet by Vector Type
    • 2.1.2. Viral Vector Production Market Snippet by Application
    • 2.1.3. Viral Vector Production Market Snippet by Indication
    • 2.1.4. Viral Vector Production Market Snippet by Country
    • 2.1.5. Viral Vector Production Market Snippet by Region
  • 2.2. Competitive Insights

3. Viral Vector Production Key Market Trends

  • 3.1. Viral Vector Production Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Viral Vector Production Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Viral Vector Production Market Opportunities
  • 3.4. Viral Vector Production Market Future Trends

4. Viral Vector Production Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Viral Vector Production Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Viral Vector Production Market Landscape

  • 6.1. Viral Vector Production Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Viral Vector Production Market - By Vector Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vector Type, 2023 & 2032 (%)
    • 7.1.2. Adenoviral Vectors
    • 7.1.3. Lentiviral Vectors
    • 7.1.4. Retroviral Vectors
    • 7.1.5. Adeno-Associated Viral Vectors
    • 7.1.6. Other Viral Vectors

8. Viral Vector Production Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Gene Therapy
    • 8.1.3. Vaccinology

9. Viral Vector Production Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Cancer
    • 9.1.3. Genetic Disorders
    • 9.1.4. Infectious Diseases
    • 9.1.5. Other Diseases

10. Viral Vector Production Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Viral Vector Production Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Viral Vector Production Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Viral Vector Production Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Viral Vector Production Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Viral Vector Production Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Viral Vector Production Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Danaher Corporation
    • 11.2.2. TAKARA HOLDINGS INC.
    • 11.2.3. Charles River Laboratories
    • 11.2.4. Andelyn Biosciences
    • 11.2.5. Thermo Fisher Scientific Inc.
    • 11.2.6. Novartis AG
    • 11.2.7. Avid Bioservices, Inc.
    • 11.2.8. Lonza
    • 11.2.9. FinVector O
    • 11.2.10. Oxford Biomedica
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us